drugset / Trial / NCT00840281
Cefprozil 500 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study is to compare the relative bioavailability of cefprozil 500 mg tablets (Teva Pharmaceuticals USA) with that of Cefzil® 500 mg tablets (Bristol-Myers Squibb) in healthy, non-smoking adults under fasting conditions.
Timeline
- Start
- 2003-09
- Primary completion
- 2003-09
- Completion
- 2003-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CEFPROZIL ANHYDROUS, (E)- | Small molecule | 500 mg | — |
Indications
No indication recorded.